NCT04698876

Brief Summary

The SALUS project is developing a new form of care, the application of self-tonometry by the patient itself, and an accompanying electronic case file connecting clinics, doctor's offices and patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
267

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2021

Typical duration for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 25, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 7, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

February 11, 2021

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2023

Completed
Last Updated

January 26, 2024

Status Verified

January 1, 2024

Enrollment Period

2.7 years

First QC Date

November 25, 2020

Last Update Submit

January 25, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of observed pressure peaks (>30% of the patient-specific target pressure)

    Measurement of intraocular pressure by means of ICareHOME, rebound tonometry or Goldmann applanation tonometry.

    7 days (outpatient) or minimum 24 hours (stationary)

Secondary Outcomes (12)

  • Quality of life (patient-oriented)

    Baseline and after 12 months

  • Visual field index (VFI)

    Baseline and after 9 and 12 months

  • Mean deviation (MD)

    Baseline and after 9 and 12 months

  • Pattern standard deviation (PSD)

    Baseline and after 9 and 12 months

  • Retinal nerve fiber layer thickness

    Baseline and after 12 months

  • +7 more secondary outcomes

Study Arms (2)

Outpatient measurement of intraocular pressure

EXPERIMENTAL

The intervention group measures its intraocular pressure itself in their home environment for 7 days at 6 a.m., 8 a.m., 12 a.m., 4 p.m., 8 p.m. and 12 p.m. with a self-tonometer (iCareHOME).

Procedure: Self-tonometry by means of ICareHOMEProcedure: Blood pressure

Stationary measurements of intraocular pressure

ACTIVE COMPARATOR

The intraocular pressure of the control group is measured by means of rebound tonometry or Goldmann applanation tonometry in a clinic for minimum 24 hours at 6 a.m., 8 a.m., 12 a.m., 4 p.m., 8 p.m. and 12 p.m.

Procedure: Intraocular measurement by means of rebound tonometry or Goldmann applanation tonometryProcedure: Blood pressure

Interventions

Outpatient measurement of intraocular pressure at home

Outpatient measurement of intraocular pressure

Stationary measurement of intraocular pressure in a clinic

Stationary measurements of intraocular pressure

Blood pressure measurement for 24 h

Outpatient measurement of intraocular pressureStationary measurements of intraocular pressure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Requirement of a stationary day and night measurement
  • Statutory health insurance
  • Verified and suspicion of glaucoma diagnosis with suspicion of pressure variations and peaks or not attained target pressure or suspicion of glaucoma progression (H40.1, H40.2 und H42.-)
  • Willingness for therapy in one of the participating clinics
  • Adequate German language skills
  • Signed and dated informed consent for study participation and data transfer
  • Legal capacity of the insurant to agree to the study participation

You may not qualify if:

  • Patients outside the catchment area of the participating clinics
  • Covering illnesses in psychiatry, neurology or other indications (e.g. impairment of independence) which make self-tonometry impossible
  • Strong communication barriers that do not allow the instruction to carry out the intervention
  • Unclear legal capacity of the potential study participants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Klinikum Dortmund

Dortmund, Germany

Location

St.-Johannes-Hospital Dortmund

Dortmund, Germany

Location

Kath. Krankenhaus Hagen, St.-Josefs-Hospital

Hagen, Germany

Location

Klinikum Luedenscheid

Lüdenscheid, Germany

Location

University Hospital Muenster

Münster, Germany

Location

Related Publications (1)

  • Oldiges K, Steinmann M, Duevel JA, Gruhn S, Diener R, Leclaire MD, Al-Nawaiseh S, Eter N; SALUS study group. SALUS-a non-inferiority trial to compare self-tonometry in glaucoma patients with regular inpatient intraocular pressure controls: study design and set-up. Graefes Arch Clin Exp Ophthalmol. 2022 Dec;260(12):3945-3955. doi: 10.1007/s00417-022-05759-7. Epub 2022 Jul 22.

Related Links

MeSH Terms

Conditions

GlaucomaPatient Participation

Interventions

Blood Pressure

Condition Hierarchy (Ancestors)

Ocular HypertensionEye DiseasesPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Vital SignsPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisHemodynamicsCardiovascular Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Nicole Eter, Prof. Dr.

    Chairholder and Head of the Department of Ophthalmology at the University Hospital Muenster

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chairholder and Head of the Department of Ophthalmology

Study Record Dates

First Submitted

November 25, 2020

First Posted

January 7, 2021

Study Start

February 11, 2021

Primary Completion

October 31, 2023

Study Completion

November 30, 2023

Last Updated

January 26, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations